此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis

2017年11月3日 更新者:Sunstar Americas
The purpose of this study is to evaluate the long-term efficacy and safety of lozenges containing probiotics in reducing gingivitis. The primary purpose of this study is to support claims from U.S. instructions for use (IFU) for GUM® PerioBalance®.

研究概览

地位

完全的

条件

干预/治疗

研究类型

介入性

注册 (实际的)

62

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Massachusetts
      • Cambridge、Massachusetts、美国、02142
        • The Forsyth Institute

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

14年 至 61年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Willing and able to read, understand and sign an Informed Consent form.
  • Good general health as evidenced by the medical history.
  • Between 18 and 65 years of age.
  • Male or female.
  • Minimum of 20 teeth, excluding crowns and third molar teeth.
  • Mean whole mouth Modified Gingival Index of greater-than or equal to 2.0 at baseline.
  • Willing to abstain from all oral hygiene procedures for 12-18 hours prior to clinical visits.
  • Willing to abstain from eating and drinking in the morning of visits, only drinking water is allowed.
  • Willing to abstain from interdental cleaning, chewing gums, oral whitening, mouth rinse and tobacco products for the study duration.
  • Able to understand and follow study directions.
  • No known history of allergy to dairy products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.

Exclusion Criteria

  • Presence of orthodontic appliances.
  • Intra-oral soft tissue lesions due to pathology or trauma
  • Patients with aggressive periodontitis, acute necrotizing ulcerative gingivitis, or gross decay at discretion of PI.
  • More than two sites with pocket depth >5mm and concomitant attachment loss of >2mm.
  • Pregnant or lactating females or females of child bearing potential not using acceptable methods of birth control (hormonal, barriers or abstinence).
  • Use of antibiotics within 3 months of enrollment
  • History of drug use that is associated with gum overgrowth (i.e., Dilantin, nifedipine, etc)
  • Chronic use of medication such as steroids, NSAIDs (more than 2-3 days/week), anti-coagulant medications, immunosuppressant medications or any other medications that in the opinion of the Investigator would interfere with the evaluation or confound interpretation of the study results. Use of low dose of acetylsalicylic acid (81 mg) is permitted.
  • Unwilling to sign a confidentiality statement and/or return the test products.
  • Medical condition which requires pre-medication prior to dental visits/procedures.
  • Immune compromised individuals (HIV, AIDS, immunosuppressive drug therapy).
  • Current use of probiotics or probiotic containing food (i.e., yogurt)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Probiotics Lozenge (twice a day)
Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.
有源比较器:Probiotics Lozenge (once a day)
Subjects take their lozenge once a day, one lozenge at night after brushing.
安慰剂比较:Placebo Lozenge (once a day)
Subjects take their lozenge once a day, one lozenge at night after brushing.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change From Baseline in Modified Gingival Index (MGI)
大体时间:4, 12 and 24 weeks

Modified Gingival Index (MGI) (Lobene, Weatherford et al. 1986) was measured on six gingival areas of all scorable teeth, using a scale of 0-4 as follows: Scores Criteria 0 Normal (absence of inflammation)

  1. Mild inflammation (slight change of color, little change in texture) of any portion of, but not the entire marginal or papillary gingival unit
  2. Mild inflammation of the entire gingival unit
  3. Moderate inflammation (moderate glazing, redness, edema and/or hypertrophy) of the marginal or papillary gingival unit
  4. Severe inflammation (marked redness and edema/hyper-trophy, spontaneous bleeding or ulceration) of the marginal or papillary gingival unit.

Whole mouth MGI scores were calculated by summing all scores and dividing by the number of examined scorable sites.

4, 12 and 24 weeks
Change From Baseline in Bleeding on Probing (BOP)
大体时间:4, 12 and 24 weeks
Bleeding on probing was assessed 30 seconds after probing. A dichotomous scoring system was used at six sites per tooth using one (1) and zero (0) for presence or absence, respectively. BOP (%) is a percentage of sites BOP.
4, 12 and 24 weeks

次要结果测量

结果测量
措施说明
大体时间
Change From Baseline in Plaque Index (PI)
大体时间:4, 12 and 24 weeks

Plaque Index of Turesky Modification of Quigley-Hein (Turesky, Gilmore et al. 1970) (PI) was scored on all natural teeth (except third molars) after disclosing with erythrosine solution. Scores Criteria:

0 No plaque

  1. Separate flecks of plaque at the cervical margin of the tooth
  2. A thin continuous band of plaque (up to one mm) at the cervical margin of the tooth
  3. A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
  4. Plaque covering at least one-third but less than two-thirds of the crown of the tooth
  5. Plaque covering two-thirds or more of the crown of the tooth
4, 12 and 24 weeks
Change From Baseline in Probing Depth (PD)
大体时间:4, 12 and 24 weeks
Periodontal pocket depth (PD) was determined with a periodontal probe at six sites per tooth rounded to the next lower whole mm.
4, 12 and 24 weeks

其他结果措施

结果测量
措施说明
大体时间
Change From Baseline in Inflammatory Markers in Gingival Crevicular
大体时间:15 days, 4, 12 and 24 weeks
Gingival Crevicular Fluid (GCF) samples will be analyzed for inflammatory cytokines/chemokines and matrix metalloproteases using multiplexing ELISA.
15 days, 4, 12 and 24 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Hatice Hasturk, DDS, PhD、The Forsyth Institute

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2013年3月1日

初级完成 (实际的)

2015年1月1日

研究完成 (实际的)

2015年3月1日

研究注册日期

首次提交

2013年3月11日

首先提交符合 QC 标准的

2013年3月12日

首次发布 (估计)

2013年3月14日

研究记录更新

最后更新发布 (实际的)

2017年12月7日

上次提交的符合 QC 标准的更新

2017年11月3日

最后验证

2017年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • CLP-2013-1-23

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅